SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021327
Filing Date
2023-05-11
Accepted
2023-05-11 16:36:03
Documents
65
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q harp-20230331.htm   iXBRL 10-Q 2810497
2 EX-31.1 harp-ex31_1.htm EX-31.1 15062
3 EX-31.2 harp-ex31_2.htm EX-31.2 15053
4 EX-32.1 harp-ex32_1.htm EX-32.1 13073
  Complete submission text file 0000950170-23-021327.txt   9438799

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT harp-20230331_lab.xml EX-101.LAB 460041
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT harp-20230331_pre.xml EX-101.PRE 336906
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT harp-20230331_cal.xml EX-101.CAL 43407
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT harp-20230331.xsd EX-101.SCH 55628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT harp-20230331_def.xml EX-101.DEF 214158
59 EXTRACTED XBRL INSTANCE DOCUMENT harp-20230331_htm.xml XML 1739592
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 23911683
SIC: 2836 Biological Products, (No Diagnostic Substances)